CINECA IRIS Institutional Research Information System

TERZOLO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.207
EU - Europa 18.303
AS - Asia 9.018
SA - Sud America 1.848
OC - Oceania 513
AF - Africa 440
Continente sconosciuto - Info sul continente non disponibili 29
Totale 49.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.987
IT - Italia 4.032
CN - Cina 3.494
DE - Germania 2.356
FR - Francia 1.588
GB - Regno Unito 1.299
JP - Giappone 1.205
ES - Italia 1.101
IE - Irlanda 1.083
SE - Svezia 1.066
BR - Brasile 849
TR - Turchia 848
UA - Ucraina 760
PL - Polonia 725
NL - Olanda 723
CA - Canada 692
KR - Corea 680
FI - Finlandia 600
IN - India 597
MX - Messico 457
AU - Australia 456
VN - Vietnam 408
AR - Argentina 379
AT - Austria 370
CH - Svizzera 345
GR - Grecia 326
BE - Belgio 294
PT - Portogallo 271
CO - Colombia 262
RU - Federazione Russa 247
IL - Israele 227
HK - Hong Kong 214
TW - Taiwan 212
RO - Romania 205
TH - Thailandia 198
SG - Singapore 177
CL - Cile 155
DK - Danimarca 150
MY - Malesia 144
HU - Ungheria 139
DZ - Algeria 131
NO - Norvegia 98
RS - Serbia 97
HR - Croazia 95
PH - Filippine 92
CZ - Repubblica Ceca 87
ID - Indonesia 86
PE - Perù 83
SA - Arabia Saudita 75
EC - Ecuador 73
IR - Iran 72
TN - Tunisia 66
SN - Senegal 56
EG - Egitto 53
NZ - Nuova Zelanda 53
SI - Slovenia 53
PK - Pakistan 46
ZA - Sudafrica 46
IQ - Iraq 45
BG - Bulgaria 37
AE - Emirati Arabi Uniti 29
SK - Slovacchia (Repubblica Slovacca) 28
KE - Kenya 27
BA - Bosnia-Erzegovina 26
VE - Venezuela 26
BY - Bielorussia 23
MA - Marocco 23
EU - Europa 21
SY - Repubblica araba siriana 17
BD - Bangladesh 16
MT - Malta 16
PA - Panama 16
CY - Cipro 15
LT - Lituania 15
OM - Oman 14
UZ - Uzbekistan 14
LB - Libano 13
LV - Lettonia 13
QA - Qatar 13
AM - Armenia 12
GT - Guatemala 10
JO - Giordania 10
MK - Macedonia 10
UY - Uruguay 10
KW - Kuwait 9
KZ - Kazakistan 9
DO - Repubblica Dominicana 8
MU - Mauritius 8
TZ - Tanzania 8
BO - Bolivia 7
GE - Georgia 7
LK - Sri Lanka 7
ME - Montenegro 7
AP - ???statistics.table.value.countryCode.AP??? 6
CU - Cuba 6
LU - Lussemburgo 6
NP - Nepal 6
PR - Porto Rico 6
LY - Libia 5
NI - Nicaragua 5
Totale 49.292
Salva come PNG Salva come JPEG
Città #
Beijing 1.834
Chandler 1.736
Fairfield 1.160
Houston 1.052
Dublin 1.028
Redwood City 891
Ashburn 722
Woodbridge 613
Ann Arbor 588
Wilmington 555
Torino 544
Seattle 535
Cambridge 447
Jacksonville 408
Warsaw 395
Medford 345
Nyköping 343
Villeurbanne 336
Milan 310
Princeton 306
Pisa 284
Vienna 256
Rome 242
Würzburg 239
Paris 227
Dong Ket 226
Dearborn 215
Shanghai 214
New York 210
Tokyo 203
Rochester 190
Istanbul 184
Buenos Aires 182
Madrid 177
London 164
Turin 163
Boston 159
Ankara 153
Guangzhou 145
Fremont 138
São Paulo 134
Barcelona 132
Taipei 132
Hangzhou 130
Toronto 129
Athens 125
Santiago 121
Berlin 117
Bogotá 113
Los Angeles 110
San Diego 108
Seoul 106
Chicago 104
Brescia 102
Munich 100
Budapest 98
Bologna 94
Nanjing 92
Brussels 89
Bangkok 88
Chengdu 86
Mexico City 83
Singapore 83
Bethesda 82
Florence 80
Sydney 78
Central 77
Bucharest 76
Adelaide 73
Helsinki 73
Moscow 73
Rotterdam 73
Boardman 71
Amsterdam 70
Birmingham 69
Lima 66
Montreal 66
Zurich 66
Porto 61
Leiden 60
Padova 60
Verona 59
Brisbane 58
Pittsburgh 58
Oslo 56
Silver Spring 56
Washington 55
Belgrade 54
Phoenix 53
Delhi 52
Düsseldorf 52
Philadelphia 51
San Francisco 50
Québec 49
Kuala Lumpur 47
New Delhi 47
Canberra 46
Pune 46
Salt Lake City 46
Baltimore 45
Totale 22.849
Salva come PNG Salva come JPEG
Nome #
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. 10.299
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors 3.633
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.000
New perspectives for mitotane treatment of adrenocortical carcinoma 955
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. 848
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. 744
Practical treatment using mitotane for adrenocortical carcinoma. 724
Hypertension and Acromegaly 653
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 629
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 622
Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: A systematic review and meta-Analysis 588
Autonomous hypercortisolism: definition and clinical implications 573
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 492
Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. 457
Management of adrenal cancer: a 2013 update. 424
AME position statement on adrenal incidentaloma. 405
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 403
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 398
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 398
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma. 393
Comparison of Two Mitotane Starting dose Regimens in Patients with Advanced Adrenocortical Carcinoma. 377
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. 358
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas 350
Combination Chemotherapy in Advanced Adrenocortical Carcinoma. 338
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE) 337
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 335
Management of adjuvant mitotane therapy following resection of adrenal cancer. 302
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 296
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 294
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 294
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 289
Thyroid and colorectal cancer screening in acromegaly patients: Should it be different from that in the general population? 287
Merits and pitfalls of mifepristone in Cushing's syndrome 284
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 283
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. 280
Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy. 274
Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas 266
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 253
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 246
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 237
Surgical remission of Cushing's syndrome reduces cardiovascular risk. 235
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 233
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 229
Adjuvant mitotane treatment for adrenocortical carcinoma 228
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 224
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 218
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 218
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease 214
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 210
Abiraterone and increased survival in metastatic prostate cancer. 205
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 200
Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period. 196
In vitro antitumor activity of progesterone in human adrenocortical carcinoma. 195
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 185
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 184
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma. 181
Predictors of morbidity and mortality in acromegaly: an Italian survey. 173
Diagnosi e terapia del carcinoma corticosurrenalico 171
Dual-Energy X-ray Absorptiometry Predictors of Vertebral Deformities in Beta-Thalassemia Major 171
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment. 164
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 163
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. 159
Acromegaly is associated with increased cancer risk: a survey in Italy 158
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 157
Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis. 154
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 149
24-hour profiles of blood pressure and heart rate in Cushing's syndrome. Evidence for differential control of cardiovascular variables by glucocorticoids. 147
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 147
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 146
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. 144
Analysis of BclI, N363S and ER22/23EK polymorphism of the glucocorticoid receptor gene in a large series of patients with adrenal incidentaloma 143
18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the Diagnosis of Primary Aldosteronism and Its Subtypes 142
Acute administration of melatonin at two opposite circadian stages does not change responses to gonadotropin releasing hormone, thyrotropin releasing hormone and ACTH in healthy adult males. 140
Laboratory differentiation of Cushing's syndrome 139
Adrenal incidentaloma, a five year experience. 133
[Subclinical Cushing's syndrome in adrenal incidentalomas] 132
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 130
Long term safety of recombinant human growth hormone (rhGH) in patients treated during childhood 130
May an adrenal incidentaloma change its nature? 129
Adjunctive treatment of adrenocortical carcinoma 127
Insights on the natural history of adrenal incidentalomas 119
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma 118
Evaluation of midnight salivary cortisol as a predictor factor for common carotid arteries intima media thickness in patients with clinically inapparent adrenal adenomas 117
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 115
Adrenal incidentalomas and subclinical Cushing's syndrome: is there evidence for glucocorticoid-induced osteoporosis? 113
Biochemical stress evaluation after medial parapatellar and subvastus approach in total knee replacement. 112
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 111
Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. 109
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 107
[Drugs and andrological side-effects] 106
Adrenocortical Carcinoma with Hypercortisolism. 106
Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study 106
Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. 105
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 104
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 102
Effects of high-intensity isokinetic exercise on salivary cortisol in athletes with different training schedules: relationships to serum cortisol and lactate 101
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 101
Evaluation of cardiovascular risk factors in patients with incidentally discovered adrenal adenoma during a follow-up longer than five years 101
La recidiva di carcinoma del cortico-surrene:trattamento chirurgico o chemioterapico? 101
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 100
Totale 39.675
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.854
article - articoli 0
book - libri 0
conference - conferenze 7.387
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.241
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.755 0 0 0 0 0 0 0 0 0 428 821 506
2019/20207.012 485 402 511 675 520 838 715 652 760 573 467 414
2020/20216.890 520 435 579 427 592 512 635 551 580 689 551 819
2021/20227.460 477 516 525 690 598 439 613 605 456 550 1.022 969
2022/202310.885 821 778 483 845 723 1.473 854 825 1.306 955 933 889
2023/20247.920 1.128 1.033 812 834 843 851 769 788 267 595 0 0
Totale 50.838